agilon health, inc.
AGL
$96.58
$3.854.15%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.37% | -2.78% | -2.09% | 5.22% | 11.79% |
| Total Other Revenue | -25.98% | -18.44% | -12.33% | -1.11% | 0.37% |
| Total Revenue | 0.32% | -2.82% | -2.11% | 5.21% | 11.76% |
| Cost of Revenue | -1.65% | -0.71% | 0.61% | 6.15% | 14.81% |
| Gross Profit | 113.29% | -646.37% | -3,405.54% | -107.85% | -311.49% |
| SG&A Expenses | -1.37% | -15.88% | -12.06% | -13.19% | -13.00% |
| Depreciation & Amortization | 4.25% | 11.81% | 16.89% | 23.85% | 30.86% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.61% | -1.27% | 0.14% | 5.34% | 13.46% |
| Operating Income | 32.11% | -29.46% | -48.29% | -7.49% | -49.19% |
| Income Before Tax | 23.54% | -46.85% | -62.40% | -3.27% | -52.54% |
| Income Tax Expenses | -54.67% | -39.16% | -13.78% | 4,417.95% | -19.08% |
| Earnings from Continuing Operations | 23.67% | -46.25% | -61.96% | -3.83% | -51.95% |
| Earnings from Discontinued Operations | 41.19% | 41.19% | 242.51% | 119.83% | 116.40% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -100.00% | -100.00% |
| Net Income | 26.44% | -46.52% | -50.43% | 19.89% | -5.71% |
| EBIT | 32.11% | -29.46% | -48.29% | -7.49% | -49.19% |
| EBITDA | 33.99% | -32.27% | -52.50% | -6.34% | -50.82% |
| EPS Basic | 26.76% | -45.60% | -49.44% | 20.87% | -4.30% |
| Normalized Basic EPS | 39.61% | -30.46% | -49.43% | -1.05% | -50.33% |
| EPS Diluted | 26.56% | -45.68% | -49.47% | 20.92% | -3.39% |
| Normalized Diluted EPS | 39.35% | -30.51% | -49.43% | -1.05% | -50.33% |
| Average Basic Shares Outstanding | 0.68% | 0.61% | 0.73% | 0.91% | 1.10% |
| Average Diluted Shares Outstanding | 1.55% | 0.71% | 0.73% | 0.91% | 1.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |